Age-Related Macular Degeneration
The Age-Related Macular Degeneration pipeline: 43 tracked drugs, 17 approved for this indication.
17 approved / phase 412 Phase 31 Phase 2/33 Phase 23 Phase 1/21 Phase 16 preclinical / unstaged
Compare the share prices of listed companies in Age-Related Macular Degeneration →
Market size not yet sourced. How markets are sized ↗